By using MDP from BCG as an antigen, our group combined the antigen with an antibody against CD10 expressed on the surface of B-ALL leukemia cells so that the combination could be recognized by cytotoxic T lymphocytes (CTLs) after entering the body. The gene discussed is MME; the disease is leukemia.